News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
613,021 Results
Type
Article (27480)
Company Profile (166)
Press Release (585374)
Multimedia
Podcasts (41)
Webinars (11)
Section
Business (191488)
Career Advice (795)
Deals (29302)
Drug Delivery (90)
Drug Development (68827)
Employer Resources (67)
FDA (13659)
Job Trends (11272)
News (284878)
Policy (24625)
Tag
2025 Best Places to Work (8)
2026 Best Places to Work (16)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1760)
Accelerated approval (51)
ADA (54)
Adcomms (14)
Allergies (161)
Alliances (39115)
ALS (202)
Alzheimer's disease (1544)
Antibody-drug conjugate (ADC) (492)
Approvals (14449)
Artificial intelligence (545)
ASCO (338)
Autoimmune disease (374)
Automation (53)
Bankruptcy (300)
Belgium (12)
Best Places to Work (9279)
BIO (56)
Biologics (79)
BIOSECURE Act (13)
Biosimilars (199)
BioSpace Insights (42)
Biotechnology (102)
Bispecific (42)
Bladder cancer (206)
Brain cancer (68)
Breast cancer (741)
Cancer (5948)
Cardiovascular disease (479)
Career advice (650)
Career pathing (7)
CAR-T (334)
CDC (38)
CDMO (78)
Celiac Disease (5)
Cell therapy (859)
Cervical cancer (56)
Clinical research (62279)
Collaboration (1778)
Commercialization (48)
Compensation (1743)
Complete response letters (58)
COVID-19 (1684)
CRISPR (103)
CRO (2)
C-suite (1076)
Cystic fibrosis (126)
Data (9118)
Decentralized trials (4)
Denatured (6)
Depression (135)
Dermatology (148)
Diabetes (682)
Diagnostics (6225)
Digital health (54)
Diversity (2)
Diversity, equity & inclusion (20)
Drug discovery (252)
Drug pricing (130)
Drug shortages (12)
Duchenne muscular dystrophy (251)
Earnings (81417)
Editorial (42)
Employer branding (8)
Employer resources (63)
ESMO (305)
Events (107239)
Executive appointments (912)
Eye disease (17)
FDA (17578)
Fibrodysplasia Ossificans Progressiva (16)
Fragile X (2)
Friedreich's ataxia (24)
Frontotemporal dementia (32)
Funding (1415)
Gene editing (202)
Generative AI (31)
Gene therapy (576)
GLP-1 (823)
Government (2706)
Grass and pollen (5)
Guidances (364)
Healthcare (14754)
Hematology (216)
HIV (70)
Huntington's disease (47)
Idiopathic pulmonary fibrosis (7)
IgA nephropathy (129)
Immunology and inflammation (193)
Immuno-oncology (111)
Indications (243)
Infectious disease (1966)
Inflammatory bowel disease (192)
Inflation Reduction Act (11)
Influenza (106)
Intellectual property (308)
Interviews (84)
IPO (13983)
IRA (32)
Job creations (2430)
Job search strategy (607)
JPM (18)
Kidney cancer (27)
Kidney disease (152)
Labor market (13)
Layoffs (163)
Leadership (9)
Legal (6329)
Licensing (88)
Liver cancer (87)
Longevity (35)
Lung cancer (842)
Lung diease (17)
Lymphoma (490)
Machine learning (41)
Management (25)
Manufacturing (908)
Marketing (32)
MASH (171)
Medical affairs (3)
Medical device (11276)
Medtech (11524)
Mergers & acquisitions (16600)
Metabolic disorders (1433)
mRNA (145)
Multiple sclerosis (195)
Multispecific (3)
NASH (8)
Netherlands (19)
Neurodegenerative disease (384)
Neuropsychiatric disorders (70)
Neuroscience (2980)
Neurotech (2)
NextGen: Class of 2026 (4701)
Non-profit (3160)
Now hiring (7)
Obesity (569)
Opinion (126)
Ovarian cancer (231)
Pain (257)
Pancreatic cancer (349)
Parkinson's disease (307)
Partnered (22)
Patents (614)
Patient advocacy (6)
Patient recruitment (688)
Patient selection (71)
Peanut (65)
People (49335)
Peptides (30)
Pharmaceutical (37)
Pharmacy benefit managers (28)
Phase 1 (19288)
Phase 2 (27169)
Phase 3 (20276)
Pipeline (11521)
Policy (199)
Postmarket research (2468)
Preclinical (8376)
Press Release (44)
Prostate cancer (302)
Psychedelics (22)
Radioligand (3)
Radiopharmaceuticals (274)
Rare diseases (1034)
Real estate (3927)
Recruiting (21)
Regenerative medicine (23)
Regulatory (20787)
Reports (38)
Research institute (1617)
Resumes & cover letters (136)
Rett syndrome (52)
RNA editing (20)
RSV (62)
Schizophrenia (166)
Series A (230)
Series B (179)
Service/supplier (5)
Sickle cell disease (133)
Special edition (9)
Spinal muscular atrophy (135)
Sponsored (19)
Startups (2487)
Stem cells (5)
Stomach cancer (6)
Substance use disorders (18)
Supply chain (87)
Switzerland (16)
Tariffs (39)
The Weekly (35)
Vaccines (707)
Venture capital (59)
Weight loss (324)
Wet AMD (4)
Women's health (132)
Worklife (5)
Date
Today (168)
Last 7 days (709)
Last 30 days (3002)
Last 365 days (24469)
2026 (22115)
2025 (24250)
2024 (28496)
2023 (32538)
2022 (42668)
2021 (45914)
2020 (43235)
2019 (34046)
2018 (25865)
2017 (24426)
2016 (24150)
2015 (30548)
2014 (26202)
2013 (22059)
2012 (24309)
2011 (24781)
2010 (24279)
Location
Africa (434)
Alabama (88)
Alaska (4)
Arizona (374)
Arkansas (15)
Asia (27241)
Australia (4106)
California (14926)
Canada (3973)
China (1114)
Colorado (645)
Connecticut (555)
Delaware (408)
Europe (51446)
Florida (2227)
Georgia (476)
Hawaii (3)
Idaho (57)
Illinois (1122)
India (100)
Indiana (559)
Iowa (25)
Japan (590)
Kansas (127)
Kentucky (41)
Louisiana (60)
Maine (33)
Maryland (1592)
Massachusetts (10184)
Michigan (359)
Minnesota (768)
Mississippi (5)
Missouri (132)
Montana (22)
Nebraska (14)
Nevada (157)
New Hampshire (67)
New Jersey (3755)
New Mexico (20)
New York (3610)
North Carolina (1682)
North Dakota (7)
Northern California (7714)
Ohio (367)
Oklahoma (23)
Oregon (29)
Pennsylvania (2764)
Puerto Rico (30)
Rhode Island (47)
South America (821)
South Carolina (86)
South Dakota (1)
Southern California (6103)
Tennessee (227)
Texas (2437)
United States (50358)
Utah (445)
Vermont (2)
Virginia (275)
Washington D.C. (53)
Washington State (1157)
West Virginia (1)
Wisconsin (115)
Wyoming (1)
613,021 Results for "cord blood america inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cryopraxis, BioNK and Radboudumc Partner to Transfer Cord Blood-Derived NK Cell Technology to Brazil
September 2, 2026
·
1 min read
Press Releases
ACG appoints Philippe Azzi as Sales Director, North America
Appointment to strengthen customer partnerships and support ACG’s expanding manufacturing presence in North America
November 6, 2026
·
1 min read
Press Releases
Resolution Therapeutics partners with the Blood Centers of America, Inc. to support broad patient access to its experimental Regenerative Macrophage Therapy in the U.S.
September 1, 2026
·
6 min read
Press Releases
Cellenkos, Inc. Announces FDA Clearance to Initiate Phase 2 Clinical Trial of CK0801 (Allogeneic Cord Blood-Derived Tregs) for Aplastic Anemia
April 27, 2026
·
5 min read
Press Releases
NervGen Receives FDA Breakthrough Therapy Designation for NVG-291 in Chronic Spinal Cord Injury
November 12, 2026
·
7 min read
Press Releases
Matricelf Reports Statistically Significant Motor Function Improvement in Preclinical Efficacy Study of Chronic Spinal Cord Injury
• 63% of treated animals achieved at least five points of motor function improvement versus 11.5% of controls, representing an approximately 5.5 times higher responder rate • Statistically significant motor function benefits demonstrated in both sexes at every assessment from Week 9 through Week 12
November 5, 2026
·
4 min read
Opinion
Blood centers can help biopharma scale cell and gene therapies
Blood centers have the donors, resources and community footprint drug sponsors need to solve supply chain issues around cell and gene therapies.
September 15, 2026
·
6 min read
·
Becky Cap
Press Releases
Bayer and America’s Grow-a-Row Continue Partnership to Fight Food Insecurity
November 4, 2026
·
3 min read
Deals
Genentech pens $1.27B deal to access Alector’s preclinical blood-brain barrier asset
After a series of clinical-stage failures, Alector is resetting around its preclinical blood-brain barrier delivery technology, securing a big pharma partnership along the way.
October 5, 2026
·
2 min read
·
Gabrielle Masson
Neuroscience
Novartis drops $125M for Sironax’s tech to cross blood-brain barrier
Novartis stands alongside Big Pharma peers that have similarly invested in technologies to penetrate the blood-brain barrier, including GSK, Roche and Eli Lilly.
September 17, 2026
·
2 min read
·
Tristan Manalac
1 of 61,303
Next